March 6, 2017 / 6:22 AM / 5 months ago

BRIEF-Argen X: Staten Biotech exercised option to develop antibody for dyslipidemia

1 Min Read

March 6 (Reuters) - Argen X BV:

* Announces that Staten Biotech exercised its option to develop therapeutic simple antibody for dyslipidemia

* Argen x is eligible to receive a double-digit royalty on ARGX-116 related income Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below